You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ctDNA

Showing 1201 - 1216 of 1,216
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Non-small-cell Lung Cancer, Lung Tumors Trial in Beijing

Unknown status
  • Carcinoma
  • +2 more
    • Beijing, Beijing, China
      Peking University People'S Hospital
    Sep 14, 2016

    Colonic Tumors Trial in Beijing (OncoCare, chemo for colorectal carcinoma)

    Not yet recruiting
    • Colonic Neoplasms
    • OncoCare
    • chemotherapy for colorectal carcinoma
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Dec 15, 2016

    or Resistance to Anti-EGFR Therapies in Metastatic Colorectal

    Completed
    • Metastatic Colorectal Cancer
    • Surrey, Sutton, United Kingdom
      The Royal Marsden NHS Foundation Trust
    Dec 16, 2016

    The Oncopanel Pilot (TOP) Study

    Completed
    • Colorectal Cancer Metastatic
    • +4 more
      • Abbotsford, British Columbia, Canada
      • +4 more
      Apr 13, 2017

      Mutational Landscape in Hepatocellular Carcinoma

      Completed
      • HepatoCellular Carcinoma
      • Cirrhosis
        • Paris, France
          INSERM
        Mar 1, 2017

        Colorectal Cancer Metastatic Trial (treated with FOLFIRI±cetuximab)

        Unknown status
        • Colorectal Cancer Metastatic
        • treated with FOLFIRI±cetuximab
        • (no location specified)
        Oct 31, 2016

        Solid Tumor. Trial in Paris, Saint-Cloud (Blood sampling)

        Unknown status
        • Solid Tumor.
        • Blood sampling
        • Paris, France
        • +2 more
        Jul 6, 2016

        Lung Adenocarcinoma, EGFR Positive NSCLC Trial (EGFR-TKI, Thoracic Hypofractionated Radiotherapy)

        Unknown status
        • Lung Adenocarcinoma
        • EGFR Positive Non-small Cell Lung Cancer
        • EGFR-TKI
        • Thoracic Hypofractionated Radiotherapy
        • (no location specified)
        May 26, 2016

        Circulating Tumor DNA in Late Stage NSCLC Patients

        Unknown status
        • Carcinoma, Non-Small-Cell Lung
        • +4 more
          • Wenzhou, Zhejiang, China
            Wenzhou Medical University
          Oct 31, 2016

          Reccurent/Metastatic Solid Tumor Disease Trial in France (Targeted therapy based on molecular profiling : Imatinib, Tumor

          Unknown status
          • Reccurent/Metastatic Solid Tumor Disease
          • Targeted therapy based on molecular profiling : Imatinib
          • +10 more
          • Dijon, France
          • +7 more
          Jul 12, 2016

          Circulating Tumor DNA and Tumor Tissue DNA by Targeted

          Completed
          • Carcinoma, Non-Small-Cell Lung
            • Beijing, China
              Peking University People's Hospital
            Dec 30, 2015

            EGFR-TKI Resistant Mutation, Nonsmall Cell Lung Cancer, AZD9291 Trial (AZD9291 80mg oral each day, Radiation therapy)

            Unknown status
            • EGFR-TKI Resistant Mutation
            • +3 more
            • AZD9291 80mg oral each day
            • Radiation therapy
            • (no location specified)
            Nov 20, 2016

            Circulating Tumor DNA of Non-Small Cell Lung Cancer

            Completed
            • Stage IIIb and IV Non Small Cell Lung Cancer
            • laboratory biomarker analysis
            • +2 more
            • Rennes, France
              CHU
            Sep 9, 2016

            Predict Gefitinib' s Efficacy for Lung Cancer by Plasma Free

            Unknown status
            • Lung Adenocarcinoma
              • (no location specified)
              Apr 13, 2016

              Monitor Natural Killer Cells and Circulating Tumor Cells in

              Unknown status
              • Triple Negative Breast Cancer
              • +2 more
              • LiquidBiopsy®, NK VueTM
              • Westlake Village, California
                Cynvenio Biosystems, Inc.
              Aug 4, 2016

              Gastrointestinal Stromal Tumors Trial (dovitinib plus imatinib)

              Withdrawn
              • Gastrointestinal Stromal Tumors
              • dovitinib plus imatinib
              • (no location specified)
              Aug 1, 2015